Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Claude Maraoui is President & CEO at Journey Medical. OQRO lists 9 transactions filed with the SEC under this name, the latest on Apr 24, 2026, each linked to the official Form 4.
President & CEO
Disclosures on record
9
Companies involved
1
Claude Maraoui bought shares on the open market in 2023 and 2024, and has not bought since 2024. Sales in 2 of the 4 years since 2023.
Claude Maraoui reported 2 open-market purchases and 10 sales since 2023; purchases in 2 different years, most recently 2024.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | $844K7×7 trades |
| 2024 | $35K1×1 trade | — |
| 2023 | $66K1×1 trade | $94K3×3 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Journey MedicalDERM
9 disclosures · Mar 2025 – Apr 2026 · 7 sold
Apr 22, 202649Kdisclosed Apr 24
DetailsOfficial recordApr 22, 202683Kdisclosed Apr 24
DetailsOfficial recordMay 2, 2025Sold~$33Kdisclosed May 5
DetailsOfficial recordMar 11, 2025Sold~$247K
DetailsOfficial recordMar 6, 2025Sold~$129Kdisclosed Mar 10
DetailsOfficial recordMar 7, 2025Sold~$75Kdisclosed Mar 10
DetailsOfficial recordMar 4, 2025Sold~$146Kdisclosed Mar 6
DetailsOfficial recordMar 3, 2025Sold~$122Kdisclosed Mar 6
DetailsOfficial recordMar 5, 2025Sold~$93Kdisclosed Mar 6
DetailsOfficial recordClaude Maraoui reported 2 open-market purchases and 10 sales here, 2023 to 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
As of the latest filing on , Claude Maraoui reported holding 2,435,990 shares of Journey Medical (DERM), worth about $9.01M at the last close of $4 (Nov 16, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Journey Medical DERM | 2,435,990 | 2.44M direct | $4 | $9.01M | Apr 22, 2026 |
Is this Claude Maraoui’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Apr 22, 2026, Claude Maraoui reported holding 2,435,990 shares of Journey Medical (DERM). At the last close of $4 on Nov 16, 2026, that is about $9.01M. This is the stake disclosed in filings, not a net worth.
Claude Maraoui bought shares on the open market in 2023 and 2024, and has not bought since 2024. Sales in 2 of the 4 years since 2023.
In SEC filings since 2023: the latest open-market purchase is from 2024; the latest open-market sale is from 2025.
Journey Medical (DERM), from 2023 to 2025: 2 purchases and 10 sales.